Despite its critical role for the production and release testing of cell products in modern cell therapies, flow cytometry remains a notoriously variable technique. However, reproducibility and consistency are of key concern when monitoring cell production processes and releases of products, such as CAR T cell therapies. Therefore, it is of great importance that in-process control and quality control measures by flow cytometry fulfill essential standardization criteria.
In this webinar series, learn how to take your standardization efforts to the next level. Find out about automated acquisition and analysis of cell products with Express Mode software tools, multi-instrument alignment across sites with new Smart Gain technology, and reproducible reagent performance with REAfintiy™ Recombinant Antibodies.
In the first of three webinars, the following topics are discussed:
The second webinar focuses on:
During the final webinar of this series, learn about: